626 related articles for article (PubMed ID: 2833686)
21. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
22. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5'-yl imidodiphosphate.
Wong CS; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1994 Feb; 268(2):653-61. PubMed ID: 8113975
[TBL] [Abstract][Full Text] [Related]
23. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.
O'Sullivan BP; Mong S
Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913
[TBL] [Abstract][Full Text] [Related]
24. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
Clark JA; Houghten R; Pasternak GW
Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
[TBL] [Abstract][Full Text] [Related]
25. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
Graeser D; Neubig RR
Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695
[TBL] [Abstract][Full Text] [Related]
26. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
Selley DE; Breivogel CS; Childers SR
Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
[TBL] [Abstract][Full Text] [Related]
27. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
28. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
Costa T; Klinz FJ; Vachon L; Herz A
Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
[TBL] [Abstract][Full Text] [Related]
29. Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.
Ramkumar V; Stiles GL
J Pharmacol Exp Ther; 1988 Sep; 246(3):1194-200. PubMed ID: 3138408
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
31. Regulation of guanine nucleotide turnover on Gi/Go by agonist-stimulated and spontaneously active muscarinic receptors in cardiac membranes.
Quist E; Satumtira N; Vasan R
Arch Biochem Biophys; 1999 Jan; 361(1):57-64. PubMed ID: 9882428
[TBL] [Abstract][Full Text] [Related]
32. [Kinetic characteristics of the effect of GTP on properties of opioid receptors].
Skliankina OA; Kurochkin IN; Varfolomeeva AD; Krekhnov BV; Zaĭtsev SV; Varfolomeev SD
Biokhimiia; 1990 Jun; 55(6):1032-42. PubMed ID: 2169905
[TBL] [Abstract][Full Text] [Related]
33. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor.
Bidlack JM
NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of ligand binding to opioid receptors: selective inhibition by ethanol?
Rapaka RS; Bhargava HN; Renugopalakrishnan V; Collins BJ
NIDA Res Monogr; 1986; 75():355-8. PubMed ID: 2828985
[TBL] [Abstract][Full Text] [Related]
35. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
Morris BJ; Millan MJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
[TBL] [Abstract][Full Text] [Related]
36. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
De Souza EB; Schmidt WK; Kuhar MJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
[TBL] [Abstract][Full Text] [Related]
37. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
38. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
Cruciani RA; Lutz RA; Munson PJ; Rodbard D
J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions.
Costa T; Lang J; Gless C; Herz A
Mol Pharmacol; 1990 Mar; 37(3):383-94. PubMed ID: 2156152
[TBL] [Abstract][Full Text] [Related]
40. Binding kinetics of delta opioid receptors differ for microsomal and synaptic sites.
Spain JW; Petta DE; Coscia CJ
Mol Pharmacol; 1988 Jul; 34(1):23-8. PubMed ID: 2839762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]